EUCTR2019-003992-21-BE进行中（未招募）1 期
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Pulmonary Fibrosis - Phase 2 Study of the Efficacy and Safety of BMS-986278 in Pulmonary Fibrosis
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •For the idiopathic pulmonary fibrosis (IPF) Cohort:
- •- Diagnosis of IPF within 7 years
- •- Female and males = 40 years of age
- •For the progressive fibrotic interstitial lung disease (PF-ILD) Cohort:
- •- Evidence of progressive ILD within the 24 months before screening
- •- Female and male = 21 years of age.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 270
排除标准
- •_Women who are of childbearing potential
- •_Active Smokers
- •_Patients with current malignancy
- •_History of allergy to BMS-986278 or related compounds
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to test the safety and effectiveness of aripiprazole against placebo in children and adolescents with Tourette’s DisorderEUCTR2012-003488-23-BEOtsuka Pharmaceutical Development & Commercialization, Inc.67
进行中（未招募）
1 期
Study of Ustekinumab in Subjects with Active Systemic Lupus ErythematosusSystemic Lupus ErythematosusEUCTR2017-001489-53-ESJanssen-Cilag International NV500
进行中（未招募）
不适用
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Methotrexate-naïve Subjects with Active Rheumatoid Arthritis - NAEUCTR2004-003295-10-ATCentocor BV600
招募中
1 期
Study to Evaluate Safety, Tolerability and Efficacy in patients with Primary Biliary Cholangitis of Saroglitazar Magnesium-III (EPICS-III).EUCTR2022-001634-10-ISZydus Therapeutics Inc.192
进行中（未招募）
1 期
A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants with Lung FibrosisPulmonary FibrosisEUCTR2019-003992-21-DEBristol-Myers Squibb International Corporation360